[Mucus models for investigation of intestinal absorption mechanisms. 1. Validation and optimization of the model].
Matthes
I
I
Pharmazeutische Entwicklung der Sandoz Pharma AG, Basel, Schweiz.
Nimmerfall
F
F
Sucker
H
H
D000818:Animals; D002021:Buffers; D004247:DNA / Q000032:analysis; D004058:Diffusion; D006023:Glycoproteins / Q000737:chemistry; D006801:Humans; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000378:metabolism*; D008954:Models, Biological; D010179:Pancreas / Q000201:enzymology; D010599:Pharmacokinetics; D012212:Rheology; D012995:Solubility; D013552:Swine
D002021:Buffers; D006023:Glycoproteins; D004247:DNA
Mucusmodelle zur Untersuchung von intestinalen Absorptionsmechanismen 1. Mitteilung: Validierung und Optimierung der Modelle.